Michael Bigby

7.8k total citations · 4 hit papers
102 papers, 4.9k citations indexed

About

Michael Bigby is a scholar working on Dermatology, Immunology and Epidemiology. According to data from OpenAlex, Michael Bigby has authored 102 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Dermatology, 18 papers in Immunology and 16 papers in Epidemiology. Recurrent topics in Michael Bigby's work include Autoimmune Bullous Skin Diseases (10 papers), Nail Diseases and Treatments (9 papers) and Dermatology and Skin Diseases (9 papers). Michael Bigby is often cited by papers focused on Autoimmune Bullous Skin Diseases (10 papers), Nail Diseases and Treatments (9 papers) and Dermatology and Skin Diseases (9 papers). Michael Bigby collaborates with scholars based in United States, Australia and United Kingdom. Michael Bigby's co-authors include Katia Georgopoulos, Arlene H. Sharpe, Philip B. Sugerman, Jinhong Wang, Árpàd Molnár, Susan Winandy, Paul W. Wu, Neil Savage, Robert S. Stern and Laurence J. Walsh and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and JAMA.

In The Last Decade

Michael Bigby

100 papers receiving 4.6k citations

Hit Papers

The ikaros gene is required for the development of all ly... 1986 2026 1999 2012 1994 2002 1996 1986 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Bigby United States 30 1.2k 1.1k 847 799 746 102 4.9k
Mats Jontell Sweden 37 404 0.3× 507 0.5× 2.1k 2.5× 547 0.7× 115 0.2× 132 4.2k
Roberto Gerli Italy 52 2.7k 2.2× 270 0.2× 325 0.4× 1.1k 1.3× 173 0.2× 267 8.0k
Noah Scheinfeld United States 34 472 0.4× 1.5k 1.4× 94 0.1× 509 0.6× 211 0.3× 191 4.0k
Sol Silverman United States 51 203 0.2× 898 0.8× 4.2k 4.9× 712 0.9× 211 0.3× 164 8.1k
Neal S. Penneys United States 35 324 0.3× 1.6k 1.5× 156 0.2× 592 0.7× 190 0.3× 179 4.1k
Christian Grønhøj Denmark 31 1.6k 1.3× 499 0.5× 133 0.2× 777 1.0× 88 0.1× 99 4.6k
Thierry Schaeverbeke France 47 2.0k 1.6× 289 0.3× 147 0.2× 889 1.1× 194 0.3× 213 6.6k
Gino Antonio Vena Italy 29 992 0.8× 1.4k 1.3× 92 0.1× 193 0.2× 236 0.3× 171 3.3k
R.A.C. GRAHAM-BROWN United Kingdom 31 464 0.4× 2.1k 1.9× 162 0.2× 295 0.4× 128 0.2× 130 3.6k
Sima Halevy Israel 28 644 0.5× 1.9k 1.7× 224 0.3× 184 0.2× 3.6k 4.8× 137 5.7k

Countries citing papers authored by Michael Bigby

Since Specialization
Citations

This map shows the geographic impact of Michael Bigby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Bigby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Bigby more than expected).

Fields of papers citing papers by Michael Bigby

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Bigby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Bigby. The network helps show where Michael Bigby may publish in the future.

Co-authorship network of co-authors of Michael Bigby

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Bigby. A scholar is included among the top collaborators of Michael Bigby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Bigby. Michael Bigby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bigby, Michael & Ramón Grimalt. (2020). Platelet-rich plasma lacks evidence of clinically significant improvement in androgenetic alopecia. Journal of the American Academy of Dermatology. 84(4). 1183–1185. 4 indexed citations
2.
Gan, Stephanie D., et al.. (2014). Evaluating the Strength of Clinical Recommendations in the Medical Literature: GRADE, SORT, and AGREE. Journal of Investigative Dermatology. 134(10). 1–5. 16 indexed citations
3.
Bigby, Michael. (2014). Understanding and evaluating systematic reviews and meta-analyses. Indian Journal of Dermatology. 59(2). 134–134. 14 indexed citations
4.
Robinson, June K. & Michael Bigby. (2011). Prevention of Melanoma With Regular Sunscreen Use. JAMA. 306(3). 302–3. 12 indexed citations
5.
Bigby, Michael, et al.. (2010). Pityriasis Versicolor. Archives of Dermatology. 146(10). 1132–40. 53 indexed citations
6.
Bigby, Michael. (2010). Why the Evidence for Skin Cancer Screening Is Insufficient. Archives of Dermatology. 146(3). 322–4. 7 indexed citations
7.
Albrecht, Joerg, Victoria P. Werth, & Michael Bigby. (2009). The role of case reports in evidence-based practice, with suggestions for improving their reporting. Journal of the American Academy of Dermatology. 60(3). 412–418. 42 indexed citations
8.
Bigby, Michael. (2004). The End of the Sunscreen and Melanoma Controversy?. Archives of Dermatology. 140(6). 745–6. 14 indexed citations
9.
Bigby, Michael. (2004). A Randomized Controlled Trial of Methotrexate and Cyclosporine in the Treatment of Psoriasis. Archives of Dermatology. 140(3). 347–8. 8 indexed citations
10.
Bigby, Michael. (2001). Challenges to the Hierarchy of Evidence: Does the Emperor Have No Clothes?. Archives of Dermatology. 137(3). 345–345. 16 indexed citations
11.
Tsao, Hensin, et al.. (2001). A meta-analysis of reverse transcriptase-polymerase chain reaction for tyrosinase mRNA as a marker for circulating tumor cells in cutaneous melanoma.. PubMed. 137(3). 325–30. 60 indexed citations
12.
Bigby, Michael. (2000). A Remarkable Result of a Double-Masked, Placebo-Controlled Trial of Erythromycin in the Treatment of Pityriasis Rosea. Archives of Dermatology. 136(6). 775–776. 12 indexed citations
13.
Bigby, Michael. (2000). Odds Ratios and Relative Risks. Archives of Dermatology. 136(6). 770–1. 12 indexed citations
14.
Sugerman, PB, Shu‐Feng Zhou, Michael Bigby, NW Savage, & LJ Walsh. (2000). Cell-mediated cytotoxicity and matrix metalloproteinases in lichen planus: A tale of chickens and eggs.. Journal of Dental Research. 79(5). 1047–1047. 1 indexed citations
15.
Sugerman, Philip B., Neil Savage, Xijing Zhou, Laurence J. Walsh, & Michael Bigby. (2000). Oral lichen planus. Clinics in Dermatology. 18(5). 533–539. 96 indexed citations
16.
Wang, Jinhong, Aliki Nichogiannopoulou, Li Wu, et al.. (1996). Selective Defects in the Development of the Fetal and Adult Lymphoid System in Mice with an Ikaros Null Mutation. Immunity. 5(6). 537–549. 502 indexed citations breakdown →
17.
Dunn, David A., et al.. (1994). T-Cell Lines Derived from Lesional Skin of Lichen Planus Patients Contain a Distinctive Population of T-Cell Receptor γδ-Bearing Cells. Journal of Investigative Dermatology. 103(3). 347–351. 29 indexed citations
18.
Bigby, Michael, Jay S. Markowitz, Paul A. Bleicher, et al.. (1993). Most gamma delta T cells develop normally in the absence of MHC class II molecules.. The Journal of Immunology. 151(9). 4465–4475. 66 indexed citations
20.
Kalivas, James, et al.. (1990). Urticaria: Clinical efficacy of cetirizine in comparison with hydroxyzine and placebo. Journal of Allergy and Clinical Immunology. 86(6). 1014–1018. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026